about
Stepwise approach to myopathy in systemic diseaseAnnexin A2 is a natural extrahepatic inhibitor of the PCSK9-induced LDL receptor degradationSLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalinkCurcumin: An effective adjunct in patients with statin-associated muscle symptoms?Statin intolerance - a question of definition.Effects of LEP G2548A and LEPR Q223R Polymorphisms on Serum Lipids and Response to Simvastatin Treatment in Chinese Patients With Primary Hyperlipidemia.ABC Transport Proteins in Cardiovascular Disease-A Brief Summary.Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin.Evaluation of drug interactions of GSK1292263 (a GPR119 agonist) with statins: from in vitro data to clinical study design.Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.Loss of HMG-CoA reductase in C. elegans causes defects in protein prenylation and muscle mitochondria.Safety of statins: an updatePlasma PCSK9 levels are elevated with acute myocardial infarction in two independent retrospective angiographic studiesStatins and breast cancer prognosis: evidence and opportunities.The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.Association of vitamin D and incident statin induced myalgia--a retrospective cohort studyStatin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: American Geriatrics Society Expert Panel on the Care of Older Adults with MultimorbidityIndividualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutionsQuinine induced simvastatin toxicity through cytochrome inhibition - a case report.Electrophysiologic and clinico-pathologic characteristics of statin-induced muscle injury.Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment.Adherence to lipid-lowering treatment: the patient perspective.Use of medications of questionable benefit in advanced dementia.Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization.Molecular mechanisms of statin intoleranceSafety of statins.Monitoring of lipids, enzymes, and creatine kinase in patients on lipid-lowering drug therapySimultaneous Bilateral Carotid Stenting for Symptomatic Bilateral High-Grade Carotid Stenosis: A Retrospective Clinical InvestigationSLCO1B1 Polymorphisms and Statin-Induced Myopathy.Management of statin intoleranceSafety and Effectiveness of Statins for Prevention of Recurrent Myocardial Infarction in 12 156 Typical Older Patients: A Quasi-Experimental Study.Cholesterol, an essential molecule: diverse roles involving cytochrome P450 enzymes.Understanding the critical disposition pathways of statins to assess drug-drug interaction risk during drug development: it's not just about OATP1B1.A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.Primary prevention of cardiovascular events in patients with major mental illness: a possible role for statins.Primary prevention of cardiovascular disease with statins in the elderly.Management of fibromyalgia in older adults.Impact of statins in outcomes of septic patients: a systematic review.
P2860
Q21090471-41DAE507-261E-4E04-BA7C-1D232AC39C43Q24294486-B3E8DD63-8E0B-419A-99BE-03674AD12F72Q24598793-B7D92AEA-9A9B-449B-BD4C-9BDE1D8A07EFQ28075647-AF8265B4-6799-4C76-A4AD-2790B12733F0Q30245218-E086C396-D8F8-42B6-B1C4-5AD1E497A747Q30277140-1144267A-2758-430E-A300-B44ADC9C4329Q30313271-669C585A-CC1C-486C-A8B5-6653F38772A6Q30490270-664B0FA7-50EF-4D5D-BA1C-1D01739EB013Q30582571-DBA22FEE-8056-4EB5-9C9D-E54C2A382435Q31131725-BDD988BD-6EA1-4595-9333-E301C475D9EBQ33740505-F1867A87-9843-4176-BA72-13100DE55048Q33949312-C9A99C74-C68E-463C-ABA7-730D5CBFDE21Q34122388-ADE3C160-EFF3-479E-BBB3-3F746BFE99D0Q34206487-5A432648-3203-4813-B5AD-C68B4446DC91Q34276618-1FB1A3A9-20BB-4619-A4B4-1E4135FE561EQ34418562-CAD95A5E-18B7-4C3A-BB80-386EC75F9FA9Q35106382-D4E97020-7E3C-49CA-A3C7-45C167ED3CA8Q35232279-7F4CA372-7167-4E18-9216-AD4A44F05A65Q35695252-263EBFCE-D763-4A6C-8B49-888AA67A7D7FQ35915932-C78C7AC6-E6D6-472E-9452-D169DC6E7F39Q36156619-1F48B8BA-4860-4DC7-845B-2CFD16DBFDF9Q36249326-E6E662AE-2528-4260-BE94-C76C33670DEFQ36335047-ED07A72B-9A80-4E83-AE41-9E61833720DCQ36394334-CAB512C0-4349-4C95-B50D-BDA1FEA2C2DAQ36398853-855573B2-9FCF-4BBC-95DD-ABFE583AE316Q36648761-C471A622-FDAB-4329-9893-13D967700EF3Q36958324-FD19E52E-4C11-4639-8CB1-D8572FC867EBQ37095088-6C9F0DFD-A1A9-49D1-A996-4EB26E85BD69Q37115301-AF1B2728-133C-42E8-92D1-80B452EF3931Q37197698-05451177-EF8E-494D-B68B-A8399585A585Q37410969-3695C81B-1EB5-4E2A-ACA9-6BBEB518DB82Q37414000-9E1EB500-1C1F-426A-AFEA-9B4F53E1544FQ37584425-BA7BDD36-C41A-4997-BDA9-6ADF07BD015EQ38012198-A7ADD27F-DF3D-4E1C-B85A-45419DE15351Q38050686-6D412529-5B62-42DB-AB7A-5FB7BDC8A758Q38113494-06E8CEF4-FD08-425F-913F-888EDF41EA10Q38151984-83C83528-5E0A-478B-AC82-45DB5BD7EFD3Q38208222-D5C07DA5-F62E-4B83-9101-3E7FF1B94793Q38250183-C2A8C525-EEA8-4FF9-A940-EC9A09BAE496Q38267132-96D3098B-E389-4110-9A85-DB00B1305E62
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Statin-induced myopathy: a review and update.
@ast
Statin-induced myopathy: a review and update.
@en
Statin-induced myopathy: a review and update.
@nl
type
label
Statin-induced myopathy: a review and update.
@ast
Statin-induced myopathy: a review and update.
@en
Statin-induced myopathy: a review and update.
@nl
prefLabel
Statin-induced myopathy: a review and update.
@ast
Statin-induced myopathy: a review and update.
@en
Statin-induced myopathy: a review and update.
@nl
P1476
Statin-induced myopathy: a review and update.
@en
P2093
Thura T Abd
P304
P356
10.1517/14740338.2011.540568
P407
P577
2011-02-23T00:00:00Z